The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis
Official Title: A Study of Efficacy and Safety of Long-acting Low Dose Ropeginterferon in Patients With Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis: a Randomized Prospective Trial
Study ID: NCT03831776
Brief Summary: To study the efficacy and safety of combination of Ro-Peg-interferon-α2b (RoPegIFN) with Bosutinib (BOS) in comparison to BOS monotherapy, as frontline therapy for newly diagnosed chronic myeloid leukemia patients, and to estimate efficacy of the addition of RoPegIFN to BOS in terms of deep molecular response with the aim of increasing the proportion of patients who may achieve treatment free remission. (NCMLSG study #NordCML012)
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Aalborg university hospital, Aalborg, , Denmark
Aarhus ..., Aarhus, , Denmark
Copenhagen ..., Copenhagen, , Denmark
Odense Universitetshospital, Odense, , Denmark
Comprehensive Cancer Center, Hematology, Helsinki, , Finland
Haukeland Universitetssjukehus, Bergen, , Norway
Oslo Universitetssykehus, Oslo, , Norway
Stavanger Universitetssjukehus, Stavanger, , Norway
Universitetssykehuset Nord Norge, Tromsø, , Norway
St Olavs Hospital, Trondheim, , Norway
Göteborg ...., Göteborg, , Sweden
Universitetssjukhuset Linköping, Linköping, , Sweden
Skåne University Hospital, Lund, , Sweden
Karolinska Universitetssjukhus, Stockholm, , Sweden
Sundsvall ..., Sundsvall, , Sweden
Norrlands Universitetssjukhus, Umeå, , Sweden
University Hospital, Uppsala, , Sweden
Universitetssjukhuset Örebro, Örebro, , Sweden
Name: Tom Christian Martinsen, md phd
Affiliation: St Olavs Hospital, Clinical of Internal Medicine
Role: STUDY_DIRECTOR
Name: Henrik Hjorth-Hansen, md phd
Affiliation: St. Olavs Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Lydia Roy, md phd
Affiliation: Centre Hospitalo-Universitaire Henri Mondor, Service d'Hematologie Clinique
Role: PRINCIPAL_INVESTIGATOR